Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 2, 2020
Grant Date -
Dec 28, 2017
app pub date -
Jun 3, 2017
filing date -
Dec 17, 2015
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This disclosure provides methods for treating cancer in a subject comprising administering to the subject an anti-PD-1 antibody and an anti-CD27 antibody. In some embodiments, the cancer is colorectal cancer, rectal cancer, colon cancer, lung cancer, melanoma, ovarian cancer, head and neck cancer, or any combination thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully